Percutaneous electrical nerve field stimulation for disorders of gut-brain interaction
Customize your policy alerts
Sign up for premerabluecrossofwashington Policy 2.01.106 alerts
Get alerted when Policy 2.01.106 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of percutaneous electrical nerve field stimulation for abdominal pain associated with disorders of gut-brain interaction, including irritable bowel syndrome and functional dyspepsia. The service is considered investigational and is not established as effective for these conditions.
The investigational policy statement was expanded from irritable bowel syndrome to abdominal pain-related disorders of gut-brain interaction, including irritable bowel syndrome and functional dyspepsia.
CPT code 64567 was added as the replacement for CPT code 0720T effective January 1, 2026.
CPT code 0720T was removed from the policy coding table.
Coverage Criteria
Percutaneous electrical nerve field stimulation
Percutaneous electrical nerve field stimulation is considered investigational for the following indication.
Examples include IB Stim, First Relief v1, and TEA Device.
Abdominal pain-related disorders of gut-brain interaction
The following abdominal pain-related disorders of gut-brain interaction are within the investigational scope of this policy.
The policy scope was expanded from irritable bowel syndrome to include abdominal pain-related disorders of gut-brain interaction, including functional dyspepsia.
Percutaneous electrical nerve field stimulation for abdominal pain associated with disorders of gut-brain interaction, including irritable bowel syndrome and functional dyspepsia, is considered investigational and is not covered. The policy scope includes, but is not limited to, devices such as IB Stim, First Relief v1, and TEA Device.
Coding Information
| 64567 | Percutaneous electrical nerve field stimulation, cranial nerves, without implantation (new code effective 01/01/26) |
| 0720T | Percutaneous electrical nerve field stimulation, cranial nerves, without implantation (code termed effective 01/01/26) |
| 0720T | CPT code for percutaneous nerve stimulation; removed from the table in the August 2026 revision. |
| 64567 | New CPT code added to replace 0720T effective January 1, 2026. |
| QHH | FDA product code |
Provider Actions
Expect denial for investigational nerve field stimulation
Percutaneous electrical nerve field stimulation for abdominal pain in individuals with disorders of gut-brain interaction, including but not limited to irritable bowel syndrome and functional dyspepsia, is considered investigational and may be denied as not covered. Examples include IB Stim, First Relief v1, and TEA Device.
Confirm investigational coverage status
Percutaneous electrical nerve field stimulation for abdominal pain-related disorders of gut-brain interaction, including irritable bowel syndrome and functional dyspepsia, is addressed as investigational. The expanded scope applies to dates of service on or after November 6, 2026.
Background
Percutaneous electrical nerve field stimulation delivers electrical impulses through percutaneous electrodes placed near cranial nerve branches in the ear to target neural pathways involved in pain processing. The devices are used in the clinical context of disorders of gut-brain interaction, in which gastrointestinal symptoms occur without an identifiable structural abnormality; examples include irritable bowel syndrome and functional dyspepsia.
The available evidence is insufficient to establish improvement in net health outcomes. The cited randomized trial was small, heterogeneous, and had short follow-up, limiting the ability to establish durable clinical benefit.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.